Journals / Türk Geriatri Dergisi / 2013 / Cilt: 16 - Sayı: 3

Postmenopozal meme kanserli hastalarda geriatrik ve geriatrik olmayan hasta gurupları: lenfovasküler invazyon önemli olarak farklıdır

Gerıatrıc versus non-gerıatrıc groups ın postmenopausal breast cancer patıents: lymphovascular ınvasıon ıs sıgnıfıcantly dıfferent

Pages
305–308
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The two groups were compared with regard to age, stage, histology, hormone receptor status, grade, lymphovascular invasion and disease free and overall survival.Results: The lymphovascular invasion rate was much higher in non-geriatric patients compared to geriatric patients (p=0.008).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Women 65 years of age or older make up one half of all new breast cancer patients.
📊
Key Findings & Data:In this retrospective analysis we evaluated whether geriatric postmenopausal breast cancer patients are different from non-geriatric patients, regarding prognostic factors and survival rates.Materials and Method: A total of 291 patients with postmenopausal breast cancer were included.
💡
Conclusion & Impact:The two groups were compared with regard to age, stage, histology, hormone receptor status, grade, lymphovascular invasion and disease free and overall survival.Results: The lymphovascular invasion rate was much higher in non-geriatric patients compared to geriatric patients (p=0.008).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Women 65 years of age or older make up one half of all new breast cancer patients. These patients are called geriatric patients. Their prognosis is better than the younger patients. Generally, they are offered less intensive treatment. In this retrospective analysis we evaluated whether geriatric postmenopausal breast cancer patients are different from non-geriatric patients, regarding prognostic factors and survival rates.Materials and Method: A total of 291 patients with postmenopausal breast cancer were included. Of these, 108 patients were in the geriatric group while 183 were in the non-geriatric group. The two groups were compared with regard to age, stage, histology, hormone receptor status, grade, lymphovascular invasion and disease free and overall survival.Results: The lymphovascular invasion rate was much higher in non-geriatric patients compared to geriatric patients (p=0.008). Disease free survival and overall survival were similar.Conclusion: Geriatric patients have more favorable prognostic factors than non-geriatric patients with postmenopausal breast cancer.

Özet

Giriş: Yeni meme kanserli kadınların yarısı 65 yaş ve üzeridir. Geriatrik hasta gurubu olarak adlandırılan (65 yaş ve üzeri) bu gurubun prognozu daha genç hastalara göre daha iyidir. Genel olarak daha az toksik kemoterapi rejimleri önerilmektedir. Bu çalışmada postmenopozal meme kanserli hastalarda geriatrik hasta gurubu ile geriatrik olmayan hasta gurubu prognostik faktörler ve sağkalım açısından karşılaştırılması amaçlanmıştır.Gereç ve Yöntem: Toplam 291 postmenopozal meme kanserli hastanın hastane kayıtları geriye dönük olarak incelendi. 108 hasta geriatrik, 183 hasta geriatrik olmayan gurupta idi. Yaş, evre, histoloji, reseptör durumu, tümör greydi, lenfovasküler invazyon, hastalıksız ve genel sağkalım açısından guruplar karşılaştırıldı.Bulgular: Prognostik faktörler açısından bakıldığında lenfovasküler invazyon oranı geriatrik olmayan hasta grubunda daha fazla idi (p=0.008). Sağkalım süreleri her iki gurupta benzerdi.Sonuç: Geriatrik meme kanserli hastaların postmenopozal meme kanserli hastalardan daha iyi prognostik faktörlere sahip olduğu düşünülebilir.

🔖

Cite This Article

BÜYÜKÇELİK, A., BENDERLİ, Y. C., ERDEN, A., ASLAN, T., AKÇA, Z., MUTLU, H. (2022). Postmenopozal meme kanserli hastalarda geriatrik ve geriatrik olmayan hasta gurupları: lenfovasküler invazyon önemli olarak farklıdır. Türk Geriatri Dergisi, Cilt: 16 - Sayı: 3, 305–308. https://ajindex.com/articles/623930

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49(1):33-64. (PMID:10200776). Greenlee RT, Murray T, Bolden S. CA Cancer J Clin 2000;50(1):7-33. (PMID:10735013). Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011 Jul- Aug;61(4):212-36. (PMID:21685461). Bergman L, Kluck HM, van Leeuwen FE, et al. The influence of age on treatment choice and survival of elderly breast cancer patients in south-eastern Netherlands: a population-based study. Eur J Cancer 1992;28A(8-9):1475-80. (PMID:1515270). Gennari R, Curigliano G, Rotmensz N, et al. Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger post- menopausal patients. Cancer 2004 Sep 15;101(6):1302-10. (PMID:15316944). Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, Bondy ML. Breast cancer treatment guidelines in older women. J Clin Oncol 2005 Feb 1;23(4):783-91. (PMID:15681522). Wyld L, Garg DK, Kumar ID, Brown H, Reed MW. Stage and treatment variation with age in postmenopausal women with breast cancer: Compliance with guidelines. Br J Cancer 2004 Apr 19;90(8):1486-91. (PMID:15083173). Burnstein HJ, Harris JR, Morrow M. Cancer of Breast. In: DeVita VT, Lawrence TS, Rosenberg SA (Eds). Cancer Principles & Practice of Oncology. 8th edition, Lippicott Williams &Wilkins, USA 2008, pp 1632-3.
  2. Somaiah N, Yarnold J. Breast Cancer. In: Price P, Sikora K, Illidge T (Eds). Treatment of Cancer, 5th edition, Edward Arnold Ltd, 338 Euston Road, Great Britain 2008, p 471. Li CI, Moe RE, Daling JR. Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med 2003 Oct 13;163(18):2149-53. (PMID:14557212). Nishimura R, Osako T, Okumura Y, Tashima R, Toyozumi Y, Arima N. Changes in the ER, PgR, HER2, p53 and Ki-67 bio- logical markers between primary and recurrent breast cancer: discordance rates and prognosis. World J Surg Oncol 2011 Oct 17;9:131. (PMID:22004841). Henson DE, Ries L, Freedman LS, Carriaga M. Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer 1991 Nov 15;68(10):2142-9. (PMID:1913453). Song YJ, Shin SH, Cho JS, Park MH, Yoon JH, Jegal YJ. The role of lymphovascular invasion as a prognostic factor in patients with lymph node-positive operable invasive bre